Struys Eduard A, Jansen Erwin E W, Salomons Gajja S
Metabolic Unit, Clinical Chemistry, VUmc Medical Center, The Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands,
J Inherit Metab Dis. 2014 May;37(3):327-32. doi: 10.1007/s10545-013-9673-4. Epub 2014 Jan 16.
We have conducted biochemical studies with commercial available pyrroline-5-carboxylate (P5C) reductase (PYCR1) to investigate whether this enzyme plays a role in L-lysine degradation. Our recent studies with antiquitin/ALDH7A1 deficient fibroblasts revealed an alternative genesis of L-pipecolic acid, and we then hypothesized that PYCR1 was responsible for the conversion of Δ(1)-piperideine-6-carboxylate (P6C) into pipecolic acid. We here present evidence that PYCR1 is indeed able to produce L-pipecolic acid from P6C preparations, and the observed K m for this conversion is of the same magnitude as the K m described for the conversion of P5C to L-proline by PYCR1. Urine samples from antiquitin deficient individuals, who accumulate P6C, were also incubated with PYCR1 which resulted in a marked decrease of P6C and a huge increase of L-pipecolic acid as measured by LC-MS/MS, confirming that indeed PYCR1 generates L-pipecolic acid from P6C.
我们使用市售的吡咯啉-5-羧酸(P5C)还原酶(PYCR1)进行了生化研究,以调查该酶是否在L-赖氨酸降解中发挥作用。我们最近对抗泛素蛋白/醛脱氢酶7A1缺陷型成纤维细胞的研究揭示了L-哌啶酸的另一种生成途径,然后我们推测PYCR1负责将Δ(1)-哌啶-6-羧酸(P6C)转化为哌啶酸。我们在此提供证据表明,PYCR1确实能够从P6C制剂中产生L-哌啶酸,并且观察到的这种转化的K m与PYCR1将P5C转化为L-脯氨酸所描述的K m大小相同。来自积累P6C的抗泛素蛋白缺陷个体的尿液样本也与PYCR1一起孵育,通过LC-MS/MS测量,结果导致P6C显著减少,L-哌啶酸大幅增加,证实PYCR1确实能从P6C生成L-哌啶酸。